偏头痛疾病负担研究进展

doi:10.3969/j.issn.1672-6731.2022.02.002

摘要/Abstract

摘要： 偏头痛是慢性病且通常终身患病，在中青年人群中患病率极高，严重损害患者健康、生活质量和生产力，对家庭、工作和社会产生巨大影响，同时也是全球经济损失的重要原因。本文拟从偏头痛流行病学研究、对个人生活的总体影响、对工作的影响、对家庭的负担、发作间期负担、共病负担和经济负担多角度阐述偏头痛疾病负担进展，量化疾病对健康的影响，为未来国家层面制定偏头痛预防与治疗策略、切实降低疾病负担提供依据。

关键词: 偏头痛, 疾病负担(非MeSH词), 综述

Abstract: Migraine is a chronic and usually lifelong disease. Migraine has a high prevalence rate in young and middle-aged people, seriously damaging the health, quality of life and productivity of patients, having a huge impact on family, work and society. It is also an important cause of global economic losses. This article intends to expound the latest burden of migraine from the perspectives of epidemiological research, overall impact, impact on work, burden on family, interictal burden, comorbid burden and economic burden, and to quantify the health impact of migraine. It will provide a basis for formulating migraine prevention strategies at the national level in the future, improving the headache medical service system and effectively reducing the burden.

Key words: Migraine, Burden of disease (not in MeSH), Review

陆佳洁, 赵红如. 偏头痛疾病负担研究进展[J]. 中国现代神经疾病杂志, 2022, 22(2): 69-72.

LU Jia-jie, ZHAO Hong-ru. Advances in the burden of migraine[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2022, 22(2): 69-72.

https://journal11.magtechjournal.com/cjcnn/CN/Y2022/V22/I2/69

参考文献

[1] GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020, 396:1204-1222.
[2] Ashina M, Katsarava Z, Do TP, Buse DC, Pozo-Rosich P, Özge A, Krymchantowski AV, Lebedeva ER, Ravishankar K, Yu S, Sacco S, Ashina S, Younis S, Steiner TJ, Lipton RB. Migraine:epidemiology and systems of care[J]. Lancet, 2021, 397:1485-1495.
[3] GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016:a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet Neurol, 2018, 17:954-976.
[4] GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016:a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet, 2017, 390:1211-1259.
[5] Ashina M. Migraine[J]. N Engl J Med, 2020, 383:1866-1876.
[6] Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States:updated age, sex, and socioeconomic-specific estimates from government health surveys[J]. Headache, 2021, 61:60-68.
[7] Yalınay Dikmen P, Onur Aysevener E, Kosak S, Ilgaz Aydınlar E, Sağduyu Kocaman A. Relationship between MIDAS, depression, anxiety and alexithymia in migraine patients[J]. Acta Neurol Belg, 2020, 120:837-844.
[8] Vo P, Fang J, Bilitou A, Laflamme AK, Gupta S. Patients' perspective on the burden of migraine in Europe:a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom[J]. J Headache Pain, 2018, 19:82.
[9] Martelletti P, Schwedt TJ, Lanteri-Minet M, Quintana R, Carboni V, Diener HC, Ruiz de la Torre E, Craven A, Rasmussen AV, Evans S, Laflamme AK, Fink R, Walsh D, Dumas P, Vo P. My migraine voice survey:a global study of disease burden among individuals with migraine for whom preventive treatments have failed[J]. J Headache Pain, 2018, 19:115.
[10] Pavlović JM, Stewart WF, Bruce CA, Gorman JA, Sun H, Buse DC, Lipton RB. Burden of migraine related to menses:results from the AMPP study[J]. J Headache Pain, 2015, 16:24.
[11] D'Amico D, Sansone E, Grazzi L, Giovannetti AM, Leonardi M, Schiavolin S, Raggi A. Multimorbidity in patients with chronic migraine and medication overuse headache[J]. Acta Neurol Scand, 2018, 138:515-522.
[12] Leonardi M, Raggi A. A narrative review on the burden of migraine:when the burden is the impact on people's life[J]. J Headache Pain, 2019, 20:41.
[13] Wong LP, Alias H, Bhoo-Pathy N, Chung I, Chong YC, Kalra S, Shah ZUBS. Impact of migraine on workplace productivity and monetary loss:a study of employees in banking sector in Malaysia[J]. J Headache Pain, 2020, 21:68.
[14] Raggi A, Covelli V, Guastafierro E, Leonardi M, Scaratti C, Grazzi L, Bartolini M, Viticchi G, Cevoli S, Pierangeli G, Tedeschi G, Russo A, Barbanti P, Aurilia C, Lovati C, Giani L, Frediani F, Di Fiore P, Bono F, Rapisarda L, D'Amico D. Validation of a self-reported instrument to assedifficulties in patients with migraine:the HEADWORK questionnaire[J]. J Headache Pain, 2018, 19:85.
[15] Steiner TJ, Stovner LJ, Katsarava Z, Lainez JM, Lampl C, Lantéri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Barré J, Andrée C. The impact of headache in Europe:principal results of the Eurolight project[J]. J Headache Pain, 2014, 15:31.
[16] Buse DC, Scher AI, Dodick DW, Reed ML, Fanning KM, Manack Adams A, Lipton RB. Impact of migraine on the family:perspectives of people with migraine and their spouse/domestic partner in the CaMEO study[J]. Mayo Clin Proc, 2016.[Epub ahead of print]
[17] Brandes JL. The migraine cycle:patient burden of migraine during and between migraine attacks[J]. Headache, 2008, 48:430-441.
[18] Lampl C, Thomas H, Stovner LJ, Tassorelli C, Katsarava Z, Laínez JM, Lantéri-Minet M, Rastenyte D, Ruiz de la Torre E, Andrée C, Steiner TJ. Interictal burden attributable to episodic headache:findings from the Eurolight project[J]. J Headache Pain, 2016, 17:9.
[19] Rains JC. Sleep and migraine:assessment and treatment of comorbid sleep disorders[J]. Headache, 2018, 58:1074-1091.
[20] Buse DC, Reed ML, Fanning KM, Bostic R, Dodick DW, Schwedt TJ, Munjal S, Singh P, Lipton RB. Comorbid and co-ccurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency:results of the migraine in America symptoms and treatment (MAST) study[J]. J Headache Pain, 2020, 21:23.
[21] Negro A, Sciattella P, Rossi D, Guglielmetti M, Martelletti P, Mennini FS. Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache centre[J]. J Headache Pain, 2019, 20:120.
[22] Polson M, Williams TD, Speicher LC, Mwamburi M, Staats PS, Tenaglia AT. Concomitant medical conditions and total cost of care in patients with migraine:a real-world claims analysis[J]. Am J Manag Care, 2020, 26(1 Suppl):3-7.
[23] Bonafede M, Sapra S, Shah N, Tepper S, Cappell K, Desai P. Direct and indirect healthcare resource utilization and costs among migraine patients in the United States[J]. Headache, 2018, 58:700-714.
[24] Yucel A, Thach A, Kumar S, Loden C, Bensink M, Goldfarb N. Estimating the economic burden of migraine on US employers[J]. Am J Manag Care, 2020, 26:e403-408.
[25] Takeshima T, Wan Q, Zhang Y, Komori M, Stretton S, Rajan N, Treuer T, Ueda K. Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea:a comprehensive review of the literature[J]. J Headache Pain, 2019, 20:111.
[26] Schwedt TJ, Hentz JG, Sahai-Srivastava S, Spare NM, Martin VT, Treppendahl C, Digre K, Bennett NL, Birlea M, Watson D, Murinova N, Robert T, Dodick DW; MOTS Investigators. Headache characteristics and burden from chronic migraine with medication overuse headache:cross-sectional observations from the Medication Overuse Treatment Strategy trial[J]. Headache, 2021, 61:351-362.
[27] National Center for Quality Control of Neurological Diseases headache Standardization Construction Working Committee. Specifications for the construction of headache clinic in China[J]. Zhongguo Zu Zhong Za Zhi, 2021, 16:187-193[.国家神经系统疾病质量控制中心头痛规范化建设工作委员会. 中国头痛门诊建设规范[J]. 中国卒中杂志, 2021, 16:187-193.]
[28] Wells RE, O'Connell N, Pierce CR, Estave P, Penzien DB, Loder E, Zeidan F, Houle TT. Effectiveness of mindfulness meditation vs headache education for adults with migraine:a randomized clinical trial[J]. JAMA Intern Med, 2021, 181:317-328.

选择文件类型/文献管理软件名称

选择包含的内容

2 偏头痛疾病负担研究进展

Advances in the burden of migraine

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	佟志勇. 颅内动脉瘤与脑血管重建术[J]. 中国现代神经疾病杂志, 2024, 24(8): 595-598.
[2]	佟志勇. 脑血管重建术历史沿革[J]. 中国现代神经疾病杂志, 2024, 24(8): 599-605.
[3]	金凌骥, 胡俊文, 李寅, 王林. 复杂颅内动脉瘤的颅内-颅内血管搭桥术[J]. 中国现代神经疾病杂志, 2024, 24(8): 606-612.
[4]	刘佩玺, 史源, 朱巍. 血流导向时代颅内全域脑血管搭桥术治疗颅内动脉瘤之应用方略[J]. 中国现代神经疾病杂志, 2024, 24(8): 613-618.
[5]	张峰, 孟凡刚. 帕金森病自主神经功能障碍丘脑底核脑深部电刺激术治疗进展[J]. 中国现代神经疾病杂志, 2024, 24(7): 510-515.
[6]	吴桂智, 田宏. Meige综合征脑深部电刺激术治疗进展[J]. 中国现代神经疾病杂志, 2024, 24(7): 516-521.
[7]	孟凡刚, 张建国. 耳后磨骨槽技术在脑深部电刺激术中的应用[J]. 中国现代神经疾病杂志, 2024, 24(7): 522-524.
[8]	陈琳, 潘华. 功能性震颤的电生理诊断[J]. 中国现代神经疾病杂志, 2024, 24(7): 573-578.
[9]	魏俊吉, 常健博. 深入基层医院普及神经外科重症管理理念[J]. 中国现代神经疾病杂志, 2024, 24(6): 403-406.
[10]	史若琳, 高秀洁, 崔家宁, 邵妍, 谢璐霜, 刘毅. 5-羟色胺与帕金森病非运动症状研究进展[J]. 中国现代神经疾病杂志, 2024, 24(6): 497-501.
[11]	李海峰. 在进入靶向治疗的时代激素仍然是重症肌无力治疗的基础[J]. 中国现代神经疾病杂志, 2024, 24(5): 295-307.
[12]	许鸿嘉, 舒崖清, 王蘋, 李蕃, 许顺良, 邱伟, 马晓宇. 抗水通道蛋白4抗体阳性视神经脊髓炎谱系疾病诊断与治疗进展[J]. 中国现代神经疾病杂志, 2024, 24(5): 308-314.
[13]	黄瑀, 廖金池, 舒崖清. 抗N-甲基-D-天冬氨酸受体脑炎睡眠障碍研究进展[J]. 中国现代神经疾病杂志, 2024, 24(5): 315-319.
[14]	刘彩云, 金涛. 树突状细胞在多发性硬化免疫治疗中的应用[J]. 中国现代神经疾病杂志, 2024, 24(5): 320-330.
[15]	王军成, 赵岳阳, 杨强, 蒯涛, 潘亚文. HMGB1基因调控胶质瘤恶性生物学行为研究进展[J]. 中国现代神经疾病杂志, 2024, 24(5): 391-397.

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

2 偏头痛疾病负担研究进展

Advances in the burden of migraine

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价